Most Popular in:
A Worry Society? CTPA Annual Business Forum
By: Jane Evison
Posted: February 12, 2007
page 2 of 3A seminar on cosmetovigilance demonstrated the success of the industry’s own voluntary scheme of monitoring and reporting adverse effects, considered essential to avoid legislation on the subject.
Afternoon speakers included Emma Meredith, MD, of CTPA, and Florian Schellauf of Colipa, focusing on upcoming issues for key ingredients, while Gerhard Nohynek, MD, of L’Oréal assessed the risk of nanotechnology in cosmetic products. Mike Brown, MD, of Boots reviewed the European Commission’s recommendation on labeling and testing for sunscreens and other current issues for the sun care sector. Bob Hefford, MD, explored the differences in meeting regulatory challenges between small- and medium-sized enterprises (SMEs) and multinationals.
External stakeholders were present on day two, which addressed risk, consumer perceptions, media and regulators. CTPA chairman John Ballington drew attention to the importance of consumer confidence by posing the question that business, society and the authorities have to tackle—who do we trust?
The round table forum, led by Tracey Brown of Sense About Science, debated the lack of scientific understanding in the population at large and its misrepresentation in the press that leads to a “worry society.” The industry needs to grab hold of the issues and promote the benefits versus the risks and capitalize on the slow backlash against the nanny state and regulation.
Bertil Heerink of Colipa led a discussion on the politics of global business, giving the Colipa perspective on the impact of the Cosmetics Directive and REACH. Panel contributors covered communicating with the consumer, walking the line with a retailer and an approach to chemical management.